- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00735293
VASER Treatment of Axillary Hyperhidrosis/Bromidrosis (VASER AxHH)
September 17, 2008 updated by: Commons Aesthetic Plastic Surgery
The Use of the VASER System in the Treatment of Axillary Hyperhidrosis and/or Axillary Bromidrosis
Patients with excessive underarm odor and sweating and/or odor are treated with the VASER system to determine the VASER's effectiveness in reducing underarm sweat and odor
Study Overview
Detailed Description
Patients with excessive underarm sweat and/or odor are recruited.
The effect that excessive underarm sweat and/or odor has on their lifestyle is evaluated.
They are surgically treated with the VASER system and followed up for 6 months to evaluate side effects, adverse events and effectiveness.
Additional lifestyle evaluations are completed for comparison to pre-surgery answers.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94306
- Commons Aesthetic Plastic Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or older
- Willing and able to appear for all scheduled, post-operative visits
- Have axillary hyperhidrosis/bromidrosis that does not respond to conventional, non-invasive treatment
Exclusion Criteria:
- under the age of 18
- have undergone a prior surgical intervention for treatment of axillary hyperhidrosis (e.g.) Skoog procedure, ETS)
- have been treated with a systemic or topical agent for axillary hyperhidrosis in the past 30 days
- are deemed inappropriate candidates for surgery due to medical or mental health reasons
- are currently being treated with investigational agents or have participated in an investigational study within 60 days prior to surgery
- elect not to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Treatment
There is only one arm to this study.
All patients will receive treatment with the VASER for their axillary hyperhidrosis/bromidrosis
|
A small incision will be made in the underarm.
A VASER probe will be inserted under the skin to break apart fat and sweat glands under the skin.
A small hollow tube will be used to draw out the broken-down skin and the incision will be closed with a stitch.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess the effectiveness of the VASER for treatment of axillary hyperhidrosis using patient self-report assessments
Time Frame: 6 months
|
6 months
|
To assess the effectiveness of the VASER for the treatment of axillary bromidrosis using patient self report assessment
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess patient's post-operative pain level following VASER using patient self report assessments.
Time Frame: 2 months
|
2 months
|
To assess patients healing time following VASER treatment of axillary hyperhidrosis
Time Frame: 6 months
|
6 months
|
To establish safe and effective procedural guidelines and surgical endpoints for the treatment of axillary hyperhidrosis using the VASER
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2007
Primary Completion (Actual)
August 1, 2008
Study Completion (Actual)
August 1, 2008
Study Registration Dates
First Submitted
August 12, 2008
First Submitted That Met QC Criteria
August 13, 2008
First Posted (Estimate)
August 14, 2008
Study Record Updates
Last Update Posted (Estimate)
September 19, 2008
Last Update Submitted That Met QC Criteria
September 17, 2008
Last Verified
September 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VASER AxHH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Axillary Hyperhidrosis
-
Dr. August Wolff GmbH & Co. KG ArzneimittelTherapeutics, Inc.Not yet recruiting
-
Ulthera, IncCompleted
-
Miramar LabsCompletedAxillary HyperhidrosisCanada
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
miraDry, Inc.Withdrawn
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
Northwestern UniversityCompletedAxillary HyperhidrosisUnited States
-
Ulthera, IncCompletedAxillary HyperhidrosisGermany
-
United States Naval Medical Center, San DiegoCandela Corp.Unknown
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
Clinical Trials on VASER
-
Sound Surgical Technologies, LLC.CompletedHealthyUnited States